TANG KEVIN 4
4 · Boundless Bio, Inc. · Filed Jul 2, 2026
Research Summary
AI-generated summary of this filing
Boundless Bio (BOLD) 10% Owner Kevin Tang Buys Shares
What Happened
Kevin Tang, a reported 10% owner of Boundless Bio (BOLD), made multiple open‑market purchases (transaction code P) totaling 107,463 shares between 2026-06-30 and 2026-07-02. The purchases break down as: 25,930 shares at a reported weighted‑average $2.54 ($65,862), 100 shares at $2.50 ($250), 71,612 shares at a weighted‑average $2.49 ($178,314), and 9,821 shares at a weighted‑average $2.49 ($24,454). Total cash outlay across these trades was about $268,880. Purchases are generally considered a bullish signal (as opposed to sales), though no motive is stated.
Key Details
- Transaction dates: 2026-06-30 (two lots), 2026-07-01, 2026-07-02. All are open‑market purchases (P).
- Reported per‑lot values: $65,862; $250; $178,314; $24,454. Total ≈ $268,880.
- Price disclosure: filing reports weighted‑average prices and notes purchases were executed in multiple transactions with price ranges reported in the footnotes (roughly $2.46–$2.60 across lots). More granular per‑trade pricing is available from the filer on request.
- Shares owned after transaction: not specified in the provided excerpt. The filing notes related entities beneficially own shares: TCP 605,296; TCPI 825,422; TCP III 605,294; TCP IV 605,296, and Mr. Tang has a pecuniary interest in those holdings.
- No indication in the provided information that the Form 4 was filed late.
Context
- Kevin Tang is reported as a 10% owner with beneficial interests through several Tang Capital entities—this is large‑owner/investor trading rather than routine employee compensation activity.
- These were straightforward open‑market purchases (not option exercises, gifts, or awards). Footnotes clarify weighted averages and price ranges and state the filer will provide per‑trade breakdowns on request.
- Retail investors often watch insider buys like this as one data point; it does not by itself prove future performance.
Insider Transaction Report
Form 4
TANG KEVIN
10% Owner
Transactions
- Purchase
Common Stock
[F1][F2]2026-06-30$2.54/sh+25,930$65,862→ 2,559,775 total(indirect: By LP) - Purchase
Common Stock
[F3][F2]2026-06-30$2.50/sh+100$250→ 2,559,875 total(indirect: By LP) - Purchase
Common Stock
[F4][F2]2026-07-01$2.49/sh+71,612$178,314→ 2,631,487 total(indirect: By LP) - Purchase
Common Stock
[F5][F2]2026-07-02$2.49/sh+9,821$24,454→ 2,641,308 total(indirect: By LP)
Footnotes (5)
- [F1]The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $2.49 to $2.60. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1 and 3 through 5.
- [F2]Tang Capital Partners, LP ("TCP") beneficially owns 605,296 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 825,422 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 605,294 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 605,296 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV.
- [F3]These shares were all purchased at $2.50.
- [F4]These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.50.
- [F5]These shares were purchased in multiple transactions at prices ranging from $2.47 to $2.50.